Medikamentöse Therapie 5 - Deutsche Gesellschaft für ...
Medikamentöse Therapie 5 - Deutsche Gesellschaft für ...
Medikamentöse Therapie 5 - Deutsche Gesellschaft für ...
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
450<br />
z 5.5 <strong>Therapie</strong>empfehlungen zu speziellen Krankheitsbildern<br />
18. Lautenschlager J (2000) Present state of medication therapy in fibromyalgia syndrome.<br />
Scand. J Rheumatol Suppl 113:32–36<br />
19. Lemstra M, Olszynski WP (2005) The effectiveness of multidisciplinary rehabilitation<br />
in the treatment of fibromyalgia: a randomized controlled trial. Clin J Pain<br />
21:166–174<br />
20. Mayhew E, Ernst E (2007) Acupuncture for fibromyalgia – a systematic review of<br />
randomized clinical trials. Rheumatology Oxford 46(5):801–804<br />
21. Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ (1996) The effect<br />
of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo<br />
controlled, modified crossover study. J Rheumatol 23:529–533<br />
22. Offenbacher M, Stucki G (2000) Physical therapy in the treatment of fibromyalgia.<br />
Scand J Rheumatol Suppl 113:78–85<br />
23. Quijada-Carrera J, Valenzuela-Castano A, Povedano-Gomez J, Fernandez-Rodriguez<br />
A, Hernanz-Mediano W, Gutierrez-Rubio A, de la Iglesia-Salgado JL, Garcia-Lopez<br />
A (1996) Comparison of tenoxicam and bromazepan in the treatment<br />
of fibromyalgia: a randomized, double-blind, placebo-controlled trial. Pain 65:<br />
221–225<br />
24. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG (1991) Treatment<br />
of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A<br />
double-blind, placebo-controlled study. Arthritis Rheum 34:552–560<br />
25. Samborski W, Stratz T, Sobieska M, Mennet P, Muller W, Schulte-Monting J<br />
(1992) Intraindividual comparison of whole body cold therapy and warm treatment<br />
with hot packs in generalized tendomyopathy. Z Rheumatol 51:25–30<br />
26. Samborski W, Stratz T, Lacki JK, Klama K, Mennet P, Muller W (1996) The<br />
5-HT3 blockers in the treatment of the primary fibromyalgia syndrome: a 10-day<br />
open study with Tropisetron at a low dose. Mater Med Pol 28:17–19<br />
27. Sorensen J, Bengtsson A, Backman E, Henriksson KG, Bengtsson M (1995) Pain<br />
analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine,<br />
ketamine. Scand J Rheumatol 24:360–365<br />
28. Thieme K, Gromnica-Ihle E, Flor H (2003) Operant behavioral treatment of fibromyalgia:<br />
a controlled study. Arthritis Rheum 49:314–320<br />
29. Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG (2004) A double-blind<br />
placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum<br />
Psychopharmacol 19 (suppl 1):S27–S35<br />
30. Wolfe F, Cathey MA, Hawley DJ (1994) A double-blind placebo controlled trial of<br />
fluoxetine in fibromyalgia. Scand J Rheumatol 23:255–259<br />
31. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell<br />
IJ, Yunus MB (1997) A prospective, longitudinal, multicenter study of service utilization<br />
and costs in fibromyalgia. Arthritis Rheum 40:1560–1570